Switching Patterns Examined for Newly Initiated TNFi Therapy in Ankylosing Spondylitis
Data show that two-thirds of patients with ankylosing spondylitis did not remain on their index TNFi therapy 2 years after treatment initiation.
Ankylosing spondylitis
Long-Term Exposure to TNFi Therapy May Not Affect Fertility in Men With Spondyloarthritis
Pregnancy and offspring outcomes were reassuring in couples where men with spondyloarthritis (SpA) were exposed to tumor necrosis factor inhibitors (TNFi), according to results from a study published in The Journal of Rheumatology. Researchers conducted a multicenter prospective study of 202 men with SpA who were exposed to TNFi therapy for a minimum of 12…
Efficacy, Safety of Intravenous Golimumab Maintained Through 1 Year in Ankylosing Spondylitis
Researchers measured the safety and efficacy of intravenous golimumab in patients with active ankylosing spondylitis through 1 year.
Concurrent TNFi, DMARD Therapy May Benefit Overweight Patients With Axial Spondyloarthritis
The use of csDMARDs with TNFi may increase the likelihood of achieving clinical response in overweight or obese patients with axial spondyloarthritis.
Detecting Erosions in Sacroiliac Joints in axSpA: MRI vs CT
In comparison with computed tomography, data showed that the volume-interpolated breathhold examination MRI technique is more sensitive than T1-weighted MRI for detecting structural damage in axial spondyloarthritis.
Examining the Clinical Implications of IL-17A Inhibition in Ankylosing Spondylitis
IL-17A inhibitors offer new options in patients with ankylosing spondylitis beyond TNFi agents.
Predicting Efficacy of Etanercept Biosimilar in Ankylosing Spondylitis
In patients with ankylosing spondylitis, detecting drug and antidrug antibody levels may facilitate treatment efficacy estimation and adjustment of medication regimens during etanercept biosimilar therapy.
Ankylosing Spondylitis Associated With Increased Risk for Venous Thromboembolism
Data show an increased risk for deep vein thrombosis and venous thromboembolism in patients with ankylosing spondylitis.
Case of Recurrent Varicella Reported After Long-Term Adalimumab Treatment for Ankylosing Spondylitis
A 34-year-old man with a history of ankylosing spondylitis presented to the hospital complaining of fever, cough, malaise, and widespread vesicular rash.
Increased Risk for Mental Disorders Noted in Patients With Axial Spondyloarthritis
Researchers sought to examine the risk for mental disorders in patients with axial spondyloarthritis.
Next post in Ankylosing Spondylitis
